Catherine Goujon, MDCorrespondence information about the author MD Catherine GoujonEmail the author MD Catherine Goujon
,
Manuelle Viguier, MD, PhD
,
Delphine Staumont-Sallé, MD, PhD
,
Claire Bernier, MD
,
Gérard Guillet, MD, PhD
,
Morad Lahfa, MD
,
,
Frédéric Cambazard, MD, PhD
,
David Bottigioli, BA
,
Sophie Grande, MD
,
Karima Dahel, MD
,
Frédéric Bérard, MD, PhD
,
Muriel Rabilloud, MD, PhD
,
Catherine Mercier, PhD
,
Jean-François Nicolas, MD, PhD
Background
Methotrexate is currently used to treat atopic dermatitis but has never been assessed versus cyclosporine in adults.
Objective
This study evaluated the efficacy and safety of methotrexate versus cyclosporine in patients with moderate-to-severe atopic dermatitis.